Monday, November 2, 2026

How Hearing Loss Increases Dementia Risk: Essential Insights for Your Cognitive Health

Hearing loss is a key modifiable risk factor for dementia, emphasizing the need for early detection and intervention to protect cognitive health.

SK Hynix’s 2026 Wage Agreement: How Increased Cash Bonuses Led to a 57% Approval Rate

SK hynix's labor and management successfully agreed on a wage and collective agreement, increasing cash bonuses from 40% to 50%.

Lunit Joins Nvidia AI Ecosystem Meeting to Explore Global Healthcare AI Partnerships

Lunit, a medical AI firm, will attend NVIDIA's AI Ecosystem meeting in Seoul, following CEO Jensen Huang's visit.

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.
Latest

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

Korea and Europe Unite for Disruptive Innovation in Biohealth and Deep Tech: What’s Next?

South Korea and Europe unite to drive innovation in biohealth and deep tech, fostering high-risk research through a new MOU.

2026’s New Radiation-Resistant RaonMedix Gear: A Game Changer for Veterinarians?

S&C Company introduces lead-free radiation protective gear for vets, addressing safety concerns amidst rising digital imaging use.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Stoboclo: How This New Osteoporosis Treatment Achieved 11.8 Billion KRW in Sales in Just One Year

Daewoong Pharmaceutical's Stoboclo, a biosimilar for osteoporosis, achieved 11.8 billion KRW in sales in its first year, marking rapid growth.

Top 3 Innovative Korean Biotech Firms Shine at Novo Nordisk Partnering Day 2026

Novo Nordisk Korea hosted Partnering Day 2026 to foster global partnerships in healthcare, highlighting innovative local biotech firms.

Revolutionizing Patient Care: How thynC AI Monitoring Transforms Hospital Safety in Seoul

Seoul Sungsim Hospital adopts AI bed monitoring system thynC to enhance patient safety and streamline nursing care management.

Limits of AI Call Centers: 54% of Customers Dissatisfied—Why Human Agents Are Still Preferred

AI call centers struggle with complex inquiries, leading to user dissatisfaction and a preference for human agents in customer service.

Why Is a Convicted Doctor Still Prescribing Controlled Substances? The Yoo Ah In Propofol Case Explained

A physician convicted for illegally administering propofol to actor Yoo Ah In continues to prescribe narcotics without penalties due to bureaucratic failures.

2026 Supplementary Budget: Support for Vulnerable Groups and Youth Jobs in an Era of High Inflation

South Korea's Health Ministry proposes a budget increase to support vulnerable groups, but faces criticism over its relevance and effectiveness.

Supply Concerns Raised from Amid Middle East Conflict; Government Says No Immediate Shortage

Concerns rise over pharmaceutical supply disruptions due to Middle East conflict; authorities monitor and prepare for potential shortages.

Over Half of Top Propofol-Using Clinics in Asia Found Violating Drug Control Law

Authorities found widespread narcotics violations in medical institutions using propofol, with over half inspected breaching regulations.

Drug Price Reform Plan Prompts Emergency Meeting by South Korean Pharma Group

The Korea Pharmaceutical and Bio-Pharma Association plans strategies to address the new drug price reform and improve the industry.

Is A Breakthrough For Thyroid Eye Disease Still Out Of Reach?

HanAll Biopharma's Phase 3 trial of batoclimab for Thyroid Eye Disease failed to show statistical significance, but safety profiles remain consistent.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.